CASI PHARMACEUTICALS, INC. (CASIF) Revenue 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$20.7MFY2025 · since FY2020: $15.0M → $20.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $20.7M | -27.4% |
| FY2024 | $28.5M | -15.8% |
| FY2023 | $33.9M | -11.0% |
| FY2022 | $38.0M | +26.7% |
| FY2021 | $30.0M | +100.1% |
| FY2020 | $15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF Net incomeCASIF Net marginCASIF Gross profitCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Operating cash flowCASIF Free cash flowCASIF Capital expendituresCASIF Return on equityCASIF Stock buybacksCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF Shareholders’ equityCASIF overview →